Skip to main content

Turn Evidence Into a Convincing Value Story

Bring clinical, economic and organizational evidence into one coherent value narrative.

Learn more

White Paper: Value Dossiers for Medical Technologies: What, When and How?

Get insights from MTRC White Papers to discover how value dossiers drive market access, reimbursement success, and strategic differentiation in MedTech

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Domains in Health Technology Assessment of Digital Health Technologies: A Mapping Review

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. 

In a recent publication, Dietz et al. examined the domains used in HTA of digital health technologies (DHT) as part of the European Digital Health Technology Assessment (EDiHTA) project. Across 44 studies, methodological documents, and HTA reports, the authors identified 13 domains and found broad consistency in established areas such as clinical effectiveness, safety, economic, and organizational aspects. In contrast, environmental, technical, legal and regulatory, and some ethical and human aspects were addressed inconsistently. The findings support a shift from developing new frameworks toward refining existing approaches and clarifying evidence requirements for DHT HTA.

Access the full-text article here.